Cargando…
Pregabalin in fibromyalgia - responder analysis from individual patient data
BACKGROUND: Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. A consensus group has defined what constitutes minimal, moderate, and substantial benefit based on pain intensity and Pa...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906437/ https://www.ncbi.nlm.nih.gov/pubmed/20602781 http://dx.doi.org/10.1186/1471-2474-11-150 |